These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 32748578)

  • 1. Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
    Hao SR; Yan R; Zhang SY; Lian JS; Cai H; Zhang XL; Zheng L; Jia HY; Hu JH; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Xin JJ; Sheng JF; Yang YD
    J Zhejiang Univ Sci B; 2020 Aug.; 21(8):628-636. PubMed ID: 32748578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.
    Wang N; Zhan Y; Zhu L; Hou Z; Liu F; Song P; Qiu F; Wang X; Zou X; Wan D; Qian X; Wang S; Guo Y; Yu H; Cui M; Tong G; Xu Y; Zheng Z; Lu Y; Hong P
    Cell Host Microbe; 2020 Sep; 28(3):455-464.e2. PubMed ID: 32707096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.
    Yan D; Liu XY; Zhu YN; Huang L; Dan BT; Zhang GJ; Gao YH
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China.
    Zhu L; Gong N; Liu B; Lu X; Chen D; Chen S; Shu H; Ma K; Xu X; Guo Z; Lu E; Chen D; Ge Q; Cai J; Jiang J; Wei L; Zhang W; Chen G; Chen Z
    Eur Urol; 2020 Jun; 77(6):748-754. PubMed ID: 32317180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Effectiveness of Interferon-α2b Against COVID-19: The Cuban Experience.
    Pereda R; González D; Rivero HB; Rivero JC; Pérez A; López LDR; Mezquia N; Venegas R; Betancourt JR; Domínguez RE
    J Interferon Cytokine Res; 2020 Sep; 40(9):438-442. PubMed ID: 32960147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-α2b induced anemia in severe coronavirus disease 2019 patients: a single centered, retrospective study.
    Li X; Liu T; Hai X; Li L
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):644-650. PubMed ID: 34698601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
    Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
    J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
    He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
    Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019.
    Hu F; Yin G; Chen Y; Song J; Ye M; Liu J; Chen C; Song Y; Tang X; Zhang Y
    Clin Respir J; 2020 Nov; 14(11):1067-1075. PubMed ID: 32750201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
    Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
    Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study.
    Wang B; Li D; Liu T; Wang H; Luo F; Liu Y
    BMC Infect Dis; 2020 Oct; 20(1):723. PubMed ID: 33008327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study.
    Xu N; Pan J; Sun L; Zhou C; Huang S; Chen M; Zhang J; Zhu T; Li J; Zhang H; Gao Y
    Front Immunol; 2022; 13():967716. PubMed ID: 35990674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: A retrospective study in two designated hospitals in Anhui, China.
    Zuo Y; Liu Y; Zhong Q; Zhang K; Xu Y; Wang Z
    J Med Virol; 2020 Nov; 92(11):2666-2674. PubMed ID: 32492211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arbidol/IFN-α2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study.
    Xu P; Huang J; Fan Z; Huang W; Qi M; Lin X; Song W; Yi L
    Microbes Infect; 2020; 22(4-5):200-205. PubMed ID: 32445881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial.
    Rahmani H; Davoudi-Monfared E; Nourian A; Khalili H; Hajizadeh N; Jalalabadi NZ; Fazeli MR; Ghazaeian M; Yekaninejad MS
    Int Immunopharmacol; 2020 Nov; 88():106903. PubMed ID: 32862111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
    Lian N; Xie H; Lin S; Huang J; Zhao J; Lin Q
    Clin Microbiol Infect; 2020 Jul; 26(7):917-921. PubMed ID: 32344167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
    Li W; Su YY; Zhi SS; Huang J; Zhuang CL; Bai WZ; Wan Y; Meng XR; Zhang L; Zhou YB; Luo YY; Ge SX; Chen YK; Ma Y
    Clin Microbiol Infect; 2020 Nov; 26(11):1556.e1-1556.e6. PubMed ID: 32653662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.